New spray-dryer to handle 20kg batches, as Juniper responds to solubility demand

By Dan Stanton contact

- Last updated on GMT

Image: iStock/garage131
Image: iStock/garage131

Related tags: Pharmaceutical industry

Juniper Pharma Services will up its solubility enhancement capabilities through the addition of a new spray-dryer at its site in Nottingham, UK.

The contract development and manufacturing organisation has ordered a PSD-1 spray dryer from vendor GEA Niro as part of a series of continued investments at its clinical materials GMP-compliant manufacturing facility.

“It is generally understood that over 80% new chemical entities are poorly water soluble which means there are challenges in developing a viable formulation,”​ Juniper SVP Claire Madden-Smith told in-Pharmatechnologist.com.

“Spray drying is one of the technologies that can be used to help overcome this challenge and hence we are experiencing demand.”

Once installed later this year, the spray dryer will be able to handle batches of up to 20kg, allowing Juniper to provide customers with particle engineering options to address issues of solubility and bioavailability among clinical candidates.

The added dryer builds on Juniper’s bench-top scale spray drying equipment, but despite the scale-up Juniper will continue to focus on clinical materials and small-scale commercial production, Madden-Smith said.

“We are focused on providing pharmaceutical development services to navigate early development, where scale and capabilities align we will work with clients on their commercial manufacturing goals.”

The investment forms part of a wider investment programme at Juniper, she continued, hinting that there will be a significant step-up in the CDMO’s capabilities over the next year. The firm will also look to increase staff numbers at the site, she added.

“Juniper Pharma Services has and continues to increase its head count regularly, and whilst the PSD-1 will actually lead to operational efficiency we still anticipate our headcount increasing throughout the year.”

The investment comes weeks after fellow Nottingham-based CDMO Quotient Clinical​ announced it was expanding its spray-drying capacity. Meanwhile a number of other third-party manufacturers have invested in such technology, including Aesica​, Pharmatek​ and Hovione​.

Related news

Show more

Related products

show more

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Roquette Oral Dose Case Study - Part IV

Roquette Oral Dose Case Study - Part IV

Roquette Pharma Solutions | 04-Dec-2017 | Case Study

Download the latest Roquette case study and learn more on how PEARLITOL® Flash mannitol and starch compound offers inert stability, fast disintegration...

Roquette Oral Dose Case Study - Part III

Roquette Oral Dose Case Study - Part III

Roquette Pharma Solutions | 27-Nov-2017 | Case Study

Download the Case Study to find out how Roquette’s SweetPearl® P 300 DC maltitol technology makes an effervescent tablet solution attractive and palatable...

Roquette Oral Dose Case Study - Part II

Roquette Oral Dose Case Study - Part II

Roquette Pharma Solutions | 06-Nov-2017 | Case Study

Download the case study and learn more on how Roquette’s taste masking technology KLEPTOSE® Linecaps (KL) allows the delivery of an efficient taste masking...

Related suppliers